FIELD: medicine.
SUBSTANCE: agent for elimination of the factor of circulatory dysfunction contains the spherical activated charcoal in quality of an effective component. Also the pharmaceutical composition, a corresponding way of treatment and application of the spherical activated charcoal on the same appointment are offered.
EFFECT: suppression of a natriuretic peptide concentration increase in blood, suppression of cardiomegaly and fibrogenesis of myocardium progression under the influence of the spherical activated charcoal.
16 cl, 9 dwg, 1 tbl
| Title | Year | Author | Number |
|---|---|---|---|
| METHOD OF PRODUCING SPHERICAL ACTIVATED CARBON | 2005 |
|
RU2375302C2 |
| ADSORBENT FOR PERORAL ADMINISTRATION AND AGENT FOR TREATMENT OR PREVENTION OF KIDNEY OR LIVER DISEASES | 2003 |
|
RU2292211C2 |
| ADSORBENT FOR PERORAL ADMINISTRATION | 2003 |
|
RU2306941C2 |
| ORAL ADSORBENT AND AGENT FOR TREATMENT OR PREVENTION OF RENAL OR HEPATIC DISEASE | 2005 |
|
RU2396965C2 |
| ADSORBENTS FOR ORAL ADMINISTRATION | 2012 |
|
RU2583934C2 |
| ORAL ADSORBENT AND AGENT FOR TREATMENT OR PREVENTION OF RENAL OR HEPATIC DISEASE | 2005 |
|
RU2396964C2 |
| MEDICAL ADSORBENT AND METHOD FOR ITS OBTAINING | 2011 |
|
RU2627464C2 |
| ACTIVATED CARBON ADSORBING PER- AND POLYFLUOROALKYL COMPOUNDS | 2020 |
|
RU2818008C2 |
| AGENT FOR PROPHYLAXIS OF INTESTINE TUMOR DISEASES | 1997 |
|
RU2132697C1 |
| COMPOSITIONS AND METHODS FOR TREATING HEART FAILURE IN DIABETIC PATIENTS | 2012 |
|
RU2650635C2 |
